VNDA Financial Facts

Total operating expenses: 39.14M
Income (loss) from operations: -653K
See Full Income Statement

Total liabilities: 79.28M
Cash and cash equivalents: 32.77M
See Full Balance Sheet

Vanda Pharma (VNDA) Earnings

| Expand Research on VNDA

Next EPS Date	5/1/24	EPS Growth Rate	-16.7%
Average EPS % Beat Rate	+35.8%	Revenue Growth Rate	+77,502.5%
Average % Move 1-Wk after EPS	-3.7%	Normal Earnings Time	After Close

Date	Qtr	EPS	Cons.	Surprise	Revs	Cons.	Gd.	Details
11/3/10	Q310	$0.11	$0.03	+$0.08	N/A	N/A	N/A	Details
2/10/11	Q410	$0.08	-$0.01	+$0.09	$7.3M	$7.55M	N/A	Details
5/5/11	Q111	$0.00	$0.00	$0.00	$7.5M	$8.13M	N/A	Details
8/4/11	Q211	-$0.05	-$0.05	$0.00	$7.4M	$8.07M	N/A	Details
11/4/11	Q311	-$0.11	-$0.08	-$0.03	$8M	$8.26M	N/A	Details
2/14/12	Q411	-$0.20	-$0.19	-$0.01	$8.4M	$8.2M	N/A	Details
5/8/12	Q112	-$0.28	-$0.16	-$0.12	$8.14M	$8.3M	N/A	Details
8/2/12	Q212	-$0.28	-$0.27	-$0.01	$8.38M	$8.3M	N/A	Details

11/7/12	Q312	-$0.19	-$0.27	+$0.08	$8.3M	$8.3M	N/A			Details
2/12/13	Q412	-$0.23	-$0.22	-$0.01	$7.9M	$8.6M	N/A			Details
5/9/13	Q113	-$0.15	-$0.25	+$0.10	$8.1M	$8.42M	N/A			Details
7/31/13	Q213	-$0.26	-$0.22	-$0.04	$8.3M	$8.43M	N/A			Details
11/7/13	Q313	-$0.43	-$0.30	-$0.13	$8.7M	$8.45M	N/A			Details
2/13/14	Q413	-$0.23	-$0.20	-$0.03	$8.8M	$8.5M	N/A			Details
4/24/14	Q114	-$0.79	-$0.30	-$0.49	$9.1M	$8.75M	N/A			Details
8/7/14	Q214	-$0.64	-$0.73	+$0.09	$10.86M	$10M	N/A			Details
10/27/14	Q314	-$0.04	-$0.39	+$0.35	$14.8M	$12.2M	N/A			Details
4/16/15	Q414	N/A	-$0.25	N/A	N/A	$20.2M	N/A	N/A	N/A
5/6/15	Q115	-$0.24	-$0.25	+$0.01	$22.2M	$20.18M	N/A			Details
7/29/15	Q215	-$0.01	-$0.29	+$0.28	$27.6M	$24.55M	N/A			Details
11/3/15	Q315	-$0.11	-$0.20	+$0.09	$28.3M	$28.84M	N/A			Details
2/10/16	Q415	-$0.35	-$0.26	-$0.09	$31.85M	$31.34M	N/A			Details
5/4/16	Q116	-$0.17	-$0.24	+$0.07	$33.3M	$32.57M	N/A			Details
7/27/16	Q216	-$0.11	-$0.23	+$0.12	N/A	$36.03M	N/A			Details
11/2/16	Q316	-$0.01	-$0.11	+$0.10	$38.5M	$38.05M	N/A			Details
2/15/17	Q416	-$0.01	-$0.09	+$0.08	$38.24M	$38.39M	=			Details
5/2/17	Q117	-$0.17	-$0.19	+$0.02	$37.4M	$38.28M	=			Details
8/2/17	Q217	$0.03	-$0.28	+$0.31	$42.06M	$40.31M	=			Details
11/7/17	Q317	-$0.03	-$0.11	+$0.08	$41.3M	$43.92M	=			Details
2/14/18	Q417	$0.03	-$0.12	+$0.15	$44.3M	$43.45M	=			Details
5/2/18	Q118	$0.14	-$0.17	+$0.31	$43.6M	$41.54M	=			Details
8/1/18	Q218	$0.14	-$0.18	+$0.32	$47.35M	$47.28M	=			Details
11/7/18	Q318	$0.13	-$0.03	+$0.16	$49.14M	$49.44M	N/A			Details
2/13/19	Q418	$0.36	$0.01	+$0.35	$53.04M	$51.7M	=			Details
5/1/19	Q119	-$0.01	$0.07	-$0.08	$47.71M	$51.74M	=			Details
7/31/19	Q219	$0.21	N/A	N/A	$59.1M	$54.15M	=			Details
11/6/19	Q319	$0.13	$0.07	+$0.06	$59.49M	$58.32M	=			Details
2/25/20	Q419	$0.08	$0.11	-$0.03	$60.9M	$59.57M	=			Details
5/6/20	Q120	$0.01	$0.00	+$0.01	$58M	$56.87M	=			Details
8/5/20	Q220	$0.16	$0.04	+$0.12	$62.21M	$61.95M	=			Details
10/28/20	Q320	$0.11	$0.09	+$0.02	$60.31M	$63.95M	=			Details
2/10/21	Q420	$0.15	$0.14	+$0.01	$67.65M	$64M	N/A			Details
5/5/21	Q121	$0.15	$0.15	$0.00	$62.67M	$68.5M	N/A			Details
7/28/21	Q221	$0.17	$0.14	+$0.03	$67.9M	$69.75M	N/A			Details
11/3/21	Q321	$0.14	$0.16	-$0.02	$70.1M	$75M	N/A			Details
2/23/22	Q421	$0.12	$0.08	+$0.04	$68M	$70.04M	=			Details
5/5/22	Q122	$0.11	-$0.01	+$0.12	$60.2M	$58M	=			Details
8/3/22	Q222	$0.05	$0.13	-$0.08	$64.4M	$67M	=			Details
11/2/22	Q322	$0.14	$0.11	+$0.03	$70.1M	$67.9M	=			Details
2/8/23	Q422	$0.12	$0.08	+$0.04	$64.5M	$67.6M	N/A			Details
5/3/23	Q123	$0.06	N/A	N/A	$62.5K	N/A	N/A			Details
7/27/23	Q223	$0.03	$0.08	-$0.05	$46.06M	$62M	N/A			Details
11/1/23	Q323	N/A	-$0.04	N/A	N/A	$44.5M	N/A	N/A	N/A
11/8/23	Q323	$0.00	-$0.04	+$0.04	$38.82M	$44.5M	N/A			Details
2/7/24	Q423	-$0.04	-$0.09	+$0.05	$45.27M	$37M	N/A			Details
5/1/24	Q124	N/A	$0.05	N/A	N/A	$48.5M	N/A	N/A	N/A

VNDA Financial Facts

Vanda Pharma (VNDA) Earnings

Free News Feed